[Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer].
Joura
E
E
II. Univers.-Frauenklinik Wien.
Gitsch
G
G
Kainz
C
C
Fröhlich
B
B
Biegelmayr
C
C
Kölbl
H
H
D000951:Antigens, Neoplasm / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000473:pathology; D009367:Neoplasm Staging; D010455:Peptides / Q000097:blood*; D015843:Serpins; D019396:Tissue Polypeptide Antigen; D014359:Trypsin Inhibitor, Kazal Pancreatic / Q000097:blood*; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D010455:Peptides; D015843:Serpins; D019396:Tissue Polypeptide Antigen; C051072:squamous cell carcinoma-related antigen; D014359:Trypsin Inhibitor, Kazal Pancreatic
Serumtumormarker SCC, TATI und TPS: Aussagekraft in der Nachsorge von Frauen mit Zervixkarzinom.